Xilio Therapeutics (XLO) stock: insider trades, news & valuation
Net buyingShare price and insider trades
Xilio Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $44K and 2 sold $6K of XLO stock on the open market.
Get emailed when insiders cluster-buy stocks like XLO
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
XLO insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | $44K | 1 | $6K | 2 |
Valuation, profit and volume
Summary
Over the past 12 months, 1 Xilio Therapeutics, Inc. insider reported open-market purchases totaling $44K, while 2 insiders reported sales totaling $6K. 2 of 2 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Mar 30SEC | James Samuel ShannonDirector | Buy | 5,00010,000 held (+100%) | $8.79 | $44K | +3.0% | — |
| Jan 5SEC | Christopher James FrankenfieldCFO | Sell Plan | 7,03024,766 held (−22%) | $0.64 | $4K | +1314.1% | — |
| Jan 5SEC | Kevin M. BrennanSvp, Finance And Accounting | Sell Plan | 1,8266,371 held (−22%) | $0.64 | $1K | +1314.1% | — |
Insiders at Xilio Therapeutics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| James Samuel ShannonDirector | $44K | — | Mar 30, 2026 | — |
| Christopher James FrankenfieldCFO | — | $4K | Jan 5, 2026 | — |
| Kevin M. BrennanSvp, Finance And Accounting | — | $1K | Jan 5, 2026 | — |
XLO stock: common questions
Are Xilio Therapeutics, Inc. insiders buying XLO stock?
In the past 12 months, 1 insiders reported open-market purchases of XLO worth $44K. The latest was Director James Samuel Shannon bought $44K of XLO at $8.79 — first open-market purchase in our records; raises the stake by 100%.
Are Xilio Therapeutics, Inc. insiders selling XLO stock?
2 insiders reported sales worth $6K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is XLO's 52-week range?
Over the past year XLO has traded between $7.14 and $11.90. It last closed at $9.05 on Oct 9, 2026.